Microbix Biosystems Inc T.MBX

Q-3

[rjc7]

Quite a vanilla report.

[Mbxwatcher]

Encouraging that a "vanilla" quarter spun off 2m in cash though. 14m in cash while just about to ramp up QAP's.  A few more deals like the one announced yesterday, and I think we may have just reported our last plain quarter.... As a long time holder of this, who suffered countless dilutive financings, (along with all of you of course), that cash number brings great comfort

[RazeKreations]

Pretty much as expected. VTM production to be ramped up in the fall as the automation is completed enabling expansion of customer base. Qaps will continue to grow substantially over time and the continued cash growth are all good for the future allowing more expansion as needed without borrowing or selling more shares. Not an exciting quarter but still headed the right direction

[wizzdumb]

Nothing exciting as expected and no ugly surprises which is nice. Cash is best ever and antigen demand returning. The focus in Q2/3 has been preparing for transformative Q4 which yesterdays announcement (finally!) confirms is not a pipe dream. The first of many hopefully.  VTM and antigens are a side show compared to QAPs potential but key contributors and diversifiers. Kinlytic remains a

[lscfa]

Co. still does not report ebitda but gives guidance in ebitda...   Qtr ending  Revenue Net income cfo Adj ebitda Gross margin Cogs ebitda margin Jun 22 5,011,025 638,502